Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shlomo Almog

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Pain & Palliative Care Pharmacotherapy|August 15, 2014
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a studyElon Eisenberg, Miri Ogintz, Shlomo Almog
The Israel Medical Association Journal : IMAJ|October 23, 2002
Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?Eytan Cohen, Shlomo Almog, Daniel Staruvin, et al.
International Journal of Hygiene and Environmental Health|January 6, 2012
Human biomonitoring in Israel: past, present, futureTamar Berman, Yona Amitai, Shlomo Almog, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Warfarin and vitamin K intake in the era of pharmacogeneticsYael Lurie, Ronen Loebstein, Daniel Kurnik, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2003
Suppression of gamma-melanocyte-stimulating hormone secretion is accompanied by salt-sensitive hypertension in the ratHaim Mayan, Xi-Ping Ni, Shlomo Almog, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
The Annals of Pharmacotherapy|October 21, 2003
Multivitamin supplements may affect warfarin anticoagulation in susceptible patientsDaniel Kurnik, Aharon Lubetsky, Ronen Loebstein, et al.
Thrombosis and Haemostasis|November 16, 2004
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trialDaniel Kurnik, Ronen Loebstein, Hadas Rabinovitz, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 14, 2011
Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in IsraelYael Lurie, Asher Gopher, Ophir Lavon, et al.
Journal of Crohn'S & Colitis|April 15, 2021
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled TrialTimna Naftali, Lihi Bar-Lev Schleider, Shlomo Almog, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Pain & Palliative Care Pharmacotherapy|August 15, 2014
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a studyElon Eisenberg, Miri Ogintz, Shlomo Almog
The Israel Medical Association Journal : IMAJ|October 23, 2002
Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?Eytan Cohen, Shlomo Almog, Daniel Staruvin, et al.
International Journal of Hygiene and Environmental Health|January 6, 2012
Human biomonitoring in Israel: past, present, futureTamar Berman, Yona Amitai, Shlomo Almog, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Warfarin and vitamin K intake in the era of pharmacogeneticsYael Lurie, Ronen Loebstein, Daniel Kurnik, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2003
Suppression of gamma-melanocyte-stimulating hormone secretion is accompanied by salt-sensitive hypertension in the ratHaim Mayan, Xi-Ping Ni, Shlomo Almog, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
The Annals of Pharmacotherapy|October 21, 2003
Multivitamin supplements may affect warfarin anticoagulation in susceptible patientsDaniel Kurnik, Aharon Lubetsky, Ronen Loebstein, et al.
Thrombosis and Haemostasis|November 16, 2004
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trialDaniel Kurnik, Ronen Loebstein, Hadas Rabinovitz, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 14, 2011
Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in IsraelYael Lurie, Asher Gopher, Ophir Lavon, et al.
Journal of Crohn'S & Colitis|April 15, 2021
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled TrialTimna Naftali, Lihi Bar-Lev Schleider, Shlomo Almog, et al.
Pageof 2